RAU’s Respiratory Care Pharmacology
xx xx xx
9TH EDITION xx
BY GARDENHIRE
xx
TESTBANK
,Description
Test ssBank s s for s s Rau’s s s Respiratory s s Care s s Pharmacology s s 9th s s Edition s s Gardenhire
Test ssBank ssfor ssRau’s ssRespiratory ssCare ssPharmacology, ss9th ssEdition, ssGardenhire, ssISBN-
10: s s 0323299687, s s ISBN-13: s s 9780323299688
Table s s of s s Contents
Unit s s I: s s Basic s s Concepts s s and s s Principles s s in s s Pharmacology
1. s s Introduction s s to s s Respiratory ssCare s s Pharmacology
2. s s Principles s s of s s Drug s s Action
3. s s Administration s s of s s Aerosolized s s Agents
4. s s Calculating s s Drug s s Doses
5. s s The s s Central s s and s s Peripheral s s Nervous s s Systems
Unit s s II: s s Drugs s s Used s s to s s Treat s s the s s Respiratory s s System
6. s s Adrenergic s s (Sympathomimetic) s s Bronchodilators
7. s s Anticholinergic s s (Parasympatholytic) s s Bronchodilators
8. s s Xanthines
9. s s Mucus-Controlling s s Drug s s Therapy
10. s s Surfactant s s Agents
11. s s Corticosteriods s s in s s Respiratory ssCare
12. s s Nonsteroidal s s Antiasthma s s Agents
13. s s Aerosolized s s Antiinfective s s Agents
14. s s Antimicrobial s s Agents
15. s s Cold s s and s s Cough s s Agents
16. s s Selected s s Agents s s of s s Pulmonary s s Value
17. s s Neonatal s s and s s Pediatric s s Aerosolized s s Drug s s Therapy
Unit s s III: s s Critical s s Care, s s Cardiovascular, s s and s s Polysomnography s s Agents
18. s s Skeletal s s Muscle s s Relaxants s s (Neuromuscular s s Blocking s s Agents)
19. s s Diuretic s s Agents
20. s s Drugs s s Affecting ss the s s Central s s Nervous s s System
21. s s Vasopressors, s s Inotropes, s s and s s Antiarrythmic s s Agents
22. s s Drugs s s Affecting ss Circulation: s s Antihypertensives, s s Antianginals, s s Antithrombotics
23. s s Sleep s s and s s Sleep s s Pharmacology
,Chapter 01: Introduction to Respiratory Care Pharmacology
ss ss ss ss ss ss
Gardenhire: Rau’s Respiratory Care Pharmacology, 9th Edition
ss ss ss ss ss ss ss
MULTIPLE s s CHOICE
1. What s s is s s the s s name s s of s s the s s receptor s s sites s s that s s are s s located s s in s s the s s peripheral
s s vasculature, s s the s s heart, ssbronchial s s muscle, s s and s s bronchial s s blood s s vessels?
a. Beta s s 2 s s receptors c. Alpha ssreceptors
b. Gamma ssreceptors d. Beta s s 1 s s receptors
ANS: s s C
Alpha ssreceptors ssare sslocated ssin ssthe ssperipheral s s vasculature, s s the s s heart, ssbronchial s s muscle,
ssand ssbronchial s s blood s s vessels.
PTS: 1
2. Which ssreceptor s s site ssresults ssin sstachycardia, ssan ssincreased sspotential ssfor ssarrhythmias,
ssand ssan s s increased s s cardiac s s output?
a. Beta s s 1 s s receptor c. Alpha s s receptor
b. Beta s s 2 s s receptor d. Delta s s receptor
ANS: s s A
Stimulation s s of s s the s s beta-1 s s receptors s s results s s in s s tachycardia, s s an s s increased s s potential
s s for s s arrhythmias, ssand s s an s s increased s s cardiac s s output. s s In s s administering s s drugs s s to s s the
s s pulmonary sssystem, s s stimulation s s of ssthe s s beta-1 s s sites s s is s s not s s desired. s s However, s s most
s s respiratory s s pharmacologic s s agents s s have s s some
beta-1 s s stimulatory
ss effect. ssPTS: 1
3. Stimulation s s of s s the s s beta s s 2 s s receptors s s causes s s
a. peripheral s s vasoconstriction ss and s s mild s s bronchoconstriction s s in ssthe s s lungs.
b. tachycardia, ssan s s increased s s potential s s for s s arrhythmias, s s and s s an s s increased s s cardiac s s output.
c. bronchodilation.
d. peripheral s s vasodilation, s s bradycardia, s s and ss decreased s s cardiac s s output.
ANS: s s C
Stimulation s s of s s the s s beta-2 s s receptors s s in s s the s s lungs s s causes s s bronchodilation.
PTS: 1
4. Acetylcholine s s stimulates s s
a. the ssVagus s s nerve.
b. the s s adrenergic s s receptors.
c. the s s sympathetic s s nervous s s system.
d. the ss cholinergic s s receptors.
ANS: s s D
Acetylcholine ssstimulates s s the s s cholinergic ssreceptors.
PTS: 1
5. What ss immunoglobulin s s antibody sssensitizes s s the s s mast s s cell?
a. Leukotrienes c. Histamine
, b. IgE d. Prostaglandins
ANS: s s B
The s s IgE ss(reagin) s s antibodies s s sensitize s s the s s mast s s cell. s s Repeated s s exposure s s to s s the s s antigen s s causes
s s the ssdegranulation s s of s s the s s mast s s cell.
PTS: 1
6. Which s s of s s the s s following s s is s s caused s s by s s histamine s s release s s from ss the s s mast ss cells?
I. Bronchodilation
II. Increased s s bronchial s s gland s s secretion
III. Increased s s amount s s of s s mucus s s present s s in s s the s s airways
a. I s s and s s II s s only c. III s s only
b. II s s and s s III s s only d. I, s s II, s s III
ANS: s s B
Histamine ssis ssalso ssa sspotent s s bronchoconstrictor. ssIn s s addition ssto s s its ssbronchoconstrictive s s activity,
s s histamine
II) ssincreases s s bronchial s s gland sssecretion, sscausing ssIII) s s an s s increase ssin ssthe ssamount s s of
s s mucus sspresent s s in s s the s s airways. s s Histamine s s may s s also s s have s s an s s effect s s on
s s vascular s s permeability s s similar ssto s s the s s effect s s of- s s SRS-A.
PTS: 1
7. A sssympathomimetic s s drug s s would s s cause s s
a. bronchodilation. c. Histamine ssrelease.
b. bronchoconstriction. d. Vagus s s nerve s s stimulation.
ANS: s s A
A sssympathomimetic ssdrug sswould sscause ssbronchodilation. ssSympathomimetic ssagents ssare ssthe ssdrugs ssmost
s s commonly s s used s s to s s reverse s s bronchospasm.
PTS: 1
8. Stimulation s s of s s the s s sympathetic s s nervous s s system s s causes s s
a. vascular ss permeability. c. bronchodilation.
b. decreased s s blood s s pressure. d. bronchoconstriction.
ANS: s s C
Sympathetic ssnervous s s system ssstimulation s s causes s s bronchodilation.
PTS: 1
9. Which ss of s s the s s following s s would s s NOT s s cause s s a s s bronchospasm ssor s s bronchoconstriction?
a. Leukotrienes c. Histamine
b. Beta s s 1 s s receptors d. Prostaglandins
ANS: s s B
Beta-1 s s receptors s s would s s not s s cause s s a s s bronchospasm s s or s s bronchoconstriction.
s s Leukotrienes s s are ssone s s of s s many s s chemical s s mediators s s released s s by s s the s s mast s s cells.
s s Leukotrienes s s cause s s a s s direct, s s strong ssbronchoconstriction. s s Histamine s s is s s also s s a
s s potent s s bronchoconstrictor. s s Prostaglandins s s cause s s a s s strong s s bronchospasm, s s especially
s s in s s asthmatic s s patients.
PTS: 1